Wave Life Sciences (WVE) News Today

$5.84
+0.15 (+2.64%)
(As of 05/14/2024 ET)
Wave Life Sciences (NASDAQ:WVE) Cut to "Hold" at StockNews.com
StockNews.com lowered Wave Life Sciences from a "buy" rating to a "hold" rating in a research report on Friday.
Wave Life Sciences (NASDAQ:WVE) Issues Quarterly Earnings Results, Misses Estimates By $0.06 EPS
Wave Life Sciences (NASDAQ:WVE - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.18) by ($0.06). The business had revenue of $12.54 million for the quarter, compared to analyst estimates of $25.67 million. During the same quarter in the previous year, the business posted ($0.27) earnings per share.
Wave Life Sciences (NASDAQ:WVE) Shares Gap Down to $5.85
Wave Life Sciences (NASDAQ:WVE) Shares Gap Down to $5.85
Wave Life Sciences (NASDAQ:WVE) Shares Down 6.2%
Wave Life Sciences (NASDAQ:WVE) Trading Down 6.2%
Wave Life Sciences (WVE) Scheduled to Post Earnings on Thursday
Wave Life Sciences (NASDAQ:WVE) will be releasing earnings before the market opens on Thursday, May 9, Zacks reports.
Wave Life Sciences (NASDAQ:WVE) Shares Up 5.5%
Wave Life Sciences (NASDAQ:WVE) Shares Up 5.5%
Wave Life Sciences Ltd (WVE)
Wave Life Sciences (NASDAQ:WVE) Trading Up 4.2%
Wave Life Sciences (NASDAQ:WVE) Shares Up 4.2%
Wave Life Sciences (NASDAQ:WVE) Trading Down 4.9%
Wave Life Sciences (NASDAQ:WVE) Trading Down 4.9%
Wave Life Sciences Ltd.
WAVE Life Sciences Ltd
Wave Life Sciences Ltd. (NASDAQ:WVE) Given Average Recommendation of "Moderate Buy" by Brokerages
Wave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight analysts that are presently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating on the compan
Wave Life Sciences (NASDAQ:WVE) Trading Up 2.6%
Wave Life Sciences (NASDAQ:WVE) Stock Price Up 2.6%
Wave Life Sciences Ltd. (NASDAQ:WVE) CFO Kyle Moran Sells 15,630 Shares
Wave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) CFO Kyle Moran sold 15,630 shares of the company's stock in a transaction dated Wednesday, April 3rd. The shares were sold at an average price of $6.17, for a total transaction of $96,437.10. Following the completion of the transaction, the chief financial officer now directly owns 33,921 shares in the company, valued at approximately $209,292.57. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Wave Life Sciences (NASDAQ:WVE) Shares Down 3.5%
Wave Life Sciences (NASDAQ:WVE) Stock Price Down 3.5%
Wave Life Sciences (NASDAQ:WVE) Given Buy Rating at Truist Financial
Truist Financial restated a "buy" rating and issued a $17.00 price target on shares of Wave Life Sciences in a research report on Monday.
Wave Life Sciences (NASDAQ:WVE) Shares Gap Up to $5.77
Wave Life Sciences (NASDAQ:WVE) Shares Gap Up to $5.77
Wave Life Sciences (NASDAQ:WVE) Trading Up 4.6%
Wave Life Sciences (NASDAQ:WVE) Trading 4.6% Higher
Wave Life Sciences (NASDAQ:WVE) Stock Price Down 10.3%
Wave Life Sciences (NASDAQ:WVE) Trading Down 10.3%
HC Wainwright Comments on Wave Life Sciences Ltd.'s Q2 2024 Earnings (NASDAQ:WVE)
Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Equities researchers at HC Wainwright issued their Q2 2024 earnings per share (EPS) estimates for Wave Life Sciences in a research note issued to investors on Thursday, March 7th. HC Wainwright analyst A. Fein forecasts that the company will ea
Wave Life Sciences Ltd. to Post Q1 2024 Earnings of ($0.21) Per Share, HC Wainwright Forecasts (NASDAQ:WVE)
Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Research analysts at HC Wainwright issued their Q1 2024 earnings estimates for Wave Life Sciences in a research note issued to investors on Thursday, March 7th. HC Wainwright analyst A. Fein forecasts that the company will earn ($0.21) per shar
Wave Life Sciences (NASDAQ:WVE) Given Sector Perform Rating at Royal Bank of Canada
Royal Bank of Canada restated a "sector perform" rating and set a $5.00 price target on shares of Wave Life Sciences in a research report on Thursday.
Wave Life Sciences (NASDAQ:WVE) Hits New 52-Week High on Strong Earnings
Wave Life Sciences (NASDAQ:WVE) Hits New 52-Week High After Strong Earnings
Get Wave Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter.

Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (Ad)

The AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.

Get the full story here.

WVE Media Mentions By Week

WVE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

WVE
News Sentiment

-0.02

0.56

Average
Medical
News Sentiment

WVE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

WVE Articles
This Week

12

2

WVE Articles
Average Week

Get Wave Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:WVE) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners